C.R. Bard Inc recalls Silastic Foley Catheters Silastic Brand Foley Catheter 30cc REF: 33416 33418 33420…
Due to stain present on the surface of affected foley catheters.
- Balloon Retention Type Catheter
- Material/Component Contamination
The FDA has posted 17 enforcement recalls from C.R. Bard Inc since 2025, including 5 Class I (most serious) recalls. Most recent report: May 27, 2026.
Due to stain present on the surface of affected foley catheters.
Labeling discrepancy; Ureteral stent actual size may not match the actual product label.
Labeling discrepancy; Ureteral stent actual size may not match the actual product label.
Labeling discrepancy; Ureteral stent actual size may not match the actual product label.
Labeling discrepancy; Ureteral stent actual size may not match the actual product label.
Foley catheter trays have incorrect inserts, user may think:1)Silicone, when it's natural rubber latex, or 2)Natural rubber latex with infection control coating, when it's silicone hydrogel with antimicrobial coating, or…
Foley catheter trays have incorrect inserts, user may think:1)Silicone, when it's natural rubber latex, or 2)Natural rubber latex with infection control coating, when it's silicone hydrogel with antimicrobial coating, or…
Foley catheter trays have incorrect inserts, user may think:1)Silicone, when it's natural rubber latex, or 2)Natural rubber latex with infection control coating, when it's silicone hydrogel with antimicrobial coating, or…
Foley catheter may have an obstructed lumen, which may result in an inability to drain the bladder, of urine and may include pelvic or abdominal pain, flank pain, bladder dysfunction, obstructive uropathy, acute kidney i…
Cather packaging may contain the incorrect French size.
Cather packaging may contain the incorrect French size.
Cather packaging may contain the incorrect French size.
Firm name as filed with the FDA: “C.R. Bard Inc”. Related firm entities may file under separate names. Source: U.S. FDA openFDA device enforcement reports. Informational only — verify with the FDA before acting.